Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-10-31 | 2024-11-22 | 241685 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-09 | 2024-04-19 | 219177 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-05 | 2024-04-12 | 224580 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-01 | 2024-01-05 | 212392 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-24 | 2017-09-22 | 11062 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2020-01-07 | 55264 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2020-01-07 | 55267 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2017-07-25 | 2017-09-22 | 16856 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Actual shortage | 2023-07-13 | 2023-07-13 | 198514 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2019-10-09 | 2019-11-04 | 95868 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2020-02-05 | 2023-03-03 | 105296 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2019-01-03 | 2019-01-17 | 71121 |
| APO-DIGOXIN | 0.25MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19326 |
| APO-DIGOXIN | 0.125MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19329 |
| APO-DIGOXIN | 0.0625MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19332 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-06-28 | 2018-12-18 | 14168 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2024-10-04 | 2024-11-15 | 239367 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2024-10-24 | 2024-11-29 | 241075 |
| APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2020-08-06 | 2020-11-23 | 121897 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2020-11-19 | 2020-11-27 | 128594 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |